Arthur F. Ryan stock trades
Director of Regeneron Pharmaceuticals
5 open-market trades reported in the last 12 months: 5 sales for $435K. Every sale was under a trading plan set up in advance. The newest was filed Jul 7.
Where Arthur F. Ryan files
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 5 |
Arthur F. Ryan's trades, as filed
Open-market buys and sales, newest first, each with its Form 4 on the SEC's site. A Plan tag marks a sale under a trading plan set up in advance.
| Stock | Trade | Traded |
|---|---|---|
| SellPlan$130K | Jul 2SEC filing | |
| SellPlan$71K | May 1SEC filing | |
| SellPlan$78K | Apr 1SEC filing |
2 more trades on record, and 1 other filing (stock award). Pro members see every trade, the shares Arthur F. Ryan held after each, and every filing.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Others who file at Regeneron Pharmaceuticals
- Leonard S. Schleifer
- George Yancopoulos
- Christopher R. Fenimore
- Jason Pitofsky
- Marion McCourt
- Andrew J. Murphy
- Daniel P. Van Plew
- Joseph J. Larosa
- Christine A. Poon
- Bonnie L. Bassler
- Huda Y. Zoghbi
- Kathryn Guarini
- Craig B. Thompson
- David P. Schenkein
- George L. Sing
- Joseph L. Goldstein
- Michael S. Brown
- N. Anthony Coles